Three-day discharge after distal pancreatectomy feasibility and effectiveness

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational cohort study at IRCCS San Raffaele in Milan, Italy, evaluating a 3-day discharge protocol after minimally invasive distal pancreatectomy. The primary goal is to determine if a 3-day hospital stay is feasible when patients have adequate home support and use opioid-sparing analgesia. Secondary goals include assessing safety and early outcomes with nurse-led post-discharge follow-up. Eligible participants are adults undergoing elective minimally invasive distal pancreatectomy, living within 50 km of the hospital, with sufficient home support and no major comorbidity (ASA ≤ 3). Exclusions include open procedures, multi-visceral or vascular resections, chronic opioid use, language barriers, and intraoperative complications.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* adult (age\>= 18 years) patients undergoing elective minimally invasive distal pancreatectomy
* patients residing or with a temporary accommodation within 50 km or a 30-minute drive from the hospital;
* patients with an adequate support system at home (defined as 24-hour support for at least the first POD7);
* no contraindications to intrathecal or opioid-sparing analgesia;
* patient who have signed the inform consent for participation in the trail;
* No preoperative medical issue requiring inhospital observation longer than three days

Exclusion Criteria:

* Patients undergoing multi-visceral resection;
* undergoing an open procedure;
* requiring vascular resection;
* having a history of chronic opioid use;
* having significant comorbidities or an American Society of Anesthesiologists (ASA) score \> 3;
* patients unabled to speak Italian;
* having a cognitive impairment;
* develoing intraoperative complications;
* difficulty to be reached after discharge (e.g., limited access to a telephone).

Where it's running

• IRCCS Ospedale San Raffaele
  Milan, Italy Recruiting

Study contacts

• Study coordinator: Nicolò Pecorelli, MD
• Email: pecorelli.nicolo@hsr.it
• Phone: +39 0226436046

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Laparoscopic versus robot-assisted left-sided pancreas removal for benign and premalignant lesions

  This trial will randomize adults needing elective left-sided pancreas removal for benign or premalignant lesions to laparoscopic or robot-assisted minimally invasive surgery to see if one approach leads to faster recovery and fewer complications.

  Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT06939023

• Energy needs after pancreatic surgery: measuring metabolism to guide nutrition

  This study tests how much energy patients need after pancreatic surgery and compares direct measurements with common estimating methods to see if standard formulas are accurate.

  Recruiting Evangelismos Hospital · Athens, Attica · NCT07703813

• Liquid biopsy biomarkers to detect and monitor pancreatic cancer

  Researchers test blood-based microRNA signals to see if they can identify pancreatic cancer risk or early disease in people with familial or hereditary risk or mucinous cysts.

  Recruiting Università Vita-Salute San Raffaele · Milan, MI · NCT07700992

• Indocyanine green–guided laparoscopic distal pancreatectomy vs standard approach for pancreatic body/tail lesions

  This trial tests whether using indocyanine green (ICG) fluorescence during laparoscopic distal pancreatectomy helps surgeons protect blood flow and structures, compared with the standard approach, in adults with pancreatic body or tail tumors.

  Recruiting Alexandria University · Alexandria · NCT07656571

• Pancreatic Surgery and New Diabetes Risk in Adults without Diabetes

  This study tests whether removing part or all of the pancreas during surgery affects blood sugar control and metabolism in adults who did not have diabetes before the operation.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT07608055

• Pancreatic Cancer Screen Test in Japan Using the Enzeavour Blood Assay

  This nationwide screening study in Japan tests the Enzeavour Pancreatic Cancer blood test in about 10,000 asymptomatic adults to see if it can help detect pancreatic cancer early.

  Recruiting at 69 sites Cosomil, Inc. · Nagakute, Aichi-ken and 68 other locations · NCT07605819

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.